CoChat

Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease

Open access
Habibović, Mirela, Versteeg, Henneke, Pelle, Aline J.M., Theuns, Dominic A.M.J., Jordaens, Luc, Pedersen, Susanne S. · 2013 · EP Europace
Cited by 23

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

AIMS: Implantable cardioverter defibrillator (ICD) therapy, which includes the risk of shocks, is considered the primary culprit of reductions in patient reported outcomes (PROs; e.g. health status and distress), thereby negating the role of underlying disease severity. We examined the relative influence of living with an ICD vs. congestive heart failure (CHF) on PROs and compared (i) ICD patients without CHF (ICD only), (ii) CHF patients without an ICD (CHF-only), and (iii) CHF patients with an ICD (ICD + CHF). METHODS AND RESULTS: Separate cohorts of ICD and CHF patients (N = 435; 75% men) completed PROs at baseline, 6 and 12 months. Groups differed on physical health status only at baseline (F((2,415)) = 7.15, P = 0.001) and on anxiety at 12 months (F((2,415)) = 4.04, P = 0.01); ICD + CHF patients had the most impaired physical health status but the lowest anxiety level followed by the ICD only and CHF only patients. Congestive heart failure only patients had the most impaired mental health status and reported the highest level of anxiety as compared to the ICD only (P < 0.001) and ICD + CHF groups (P = 0.009), while the two latter groups did not differ. The effect sizes ranged from very small (0.03) to moderate-large (0.69). Groups did not differ in depression scores. CONCLUSION: Congestive heart failure patients reported worse PROs as compared to ICD patients, although the magnitude of the differences was relatively small. This suggests that the well being of patients is not necessarily negatively influenced by the implantation of an ICD, and that underlying heart disease may have at least an equal if not greater influence on PROs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/eus295

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 20

  1. Brignole, 2009, Are complications of implantable defibrillators under-estimated and benefits over-estimated?, Europace, 11, 1129, 10.1093/europace/eup174 · DOI
  2. Tung, 2008, A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death, J Am Coll Cardiol, 52, 1111, 10.1016/j.jacc.2008.05.058 · DOI · Paper page
  3. Passman, 2007, Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study, Arch Intern Med, 167, 2226, 10.1001/archinte.167.20.2226 · DOI · Paper page
  4. Redhead, 2010, Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study, J Psychosom Res, 69, 555, 10.1016/j.jpsychores.2010.06.002 · DOI
  5. Epstein, 2009, Subject of the year: who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy, J Interv Card Electrophysiol, 26, 91, 10.1007/s10840-009-9439-y · DOI
  6. Pedersen, 2010, Pre implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable carioverter defibrillator, Europace, 12, 1446, 10.1093/europace/euq296 · DOI · Paper page
  7. Pelle, 2009, Beyond Type D personality: reduced positive affect (anhedonia) predicts impaired health status in chronic heart failure, Qual Life Res, 18, 689, 10.1007/s11136-009-9485-z · DOI · Paper page
  8. Ware, 1996, A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity, Medical Care, 34, 220, 10.1097/00005650-199603000-00003 · DOI · Paper page
  9. Gandek, 1998, Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment, Journal of Clinical Epidemiology, 51, 1171, 10.1016/S0895-4356(98)00109-7 · DOI · Paper page
  10. Ware, 1995, Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study, Med Care, 33, AS264
  11. Mols, 2009, Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population, Qual Life Res, 18, 403, 10.1007/s11136-009-9455-5 · DOI · Paper page
  12. Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page
  13. Spinhoven, 1997, A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects, Psychol Med, 27, 363, 10.1017/S0033291796004382 · DOI · Paper page
  14. Van Ginkel, 2005, SPSS syntax for missing value imputation in test and questionnaire data, Appl Psych Meas, 29, 152, 10.1177/0146621603260688 · DOI
  15. Pedersen, 2011, Patient reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification, Europace, 13, 109, 10.1093/europace/eur157 · DOI
  16. Thomas, 2009, Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators, Heart Lung, 38, 109, 10.1016/j.hrtlng.2008.05.005 · DOI
  17. Pedersen, 2011, Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator, Am J Cardiol, 108, 69, 10.1016/j.amjcard.2011.02.344 · DOI
  18. Whang, 2005, Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study, J Am Coll Cardiol, 45, 1090, 10.1016/j.jacc.2004.12.053 · DOI · Paper page
  19. Pedersen, 2007, Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations, Pacing Clin Electrophysiol, 30, 1546, 10.1111/j.1540-8159.2007.00905.x · DOI · Paper page
  20. Dunbar, 2009, Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients, Pacing Clin Electrophysiol, 32, 1259, 10.1111/j.1540-8159.2009.02495.x · DOI · Paper page

Cited by

See all 23

Metadata

Authors
Habibović, M., Versteeg, H., Pelle, A. J. M., Theuns, D. A. M. J., Jordaens, L., & Pedersen, S. S.
Venue
EP Europace
Published
2012-09-18
Volume
15
Issue
3
Pages
355-361
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2123863957
Cited by
23
References
11
FWCI
1.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. https://app.cochat.ai/papers/10.1093/europace/eus295
The paper
Habibović, M., Versteeg, H., Pelle, A. J. M., Theuns, D. A. M. J., Jordaens, L., & Pedersen, S. S. (2013). Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. EP Europace. https://doi.org/10.1093/europace/eus295

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.